Skip to content
Oncology Research Hub

Wisconsin

Cancer clinical trials in Wisconsin

274 cancer studies are recruiting participants at sites in 62 cities across Wisconsin as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Wisconsin city with a recruiting study

By research area: Lymphoma (73), Breast Cancer (63), Lung Cancer (55), Prostate Cancer (45), Pancreatic Cancer (28), Melanoma (10).

Milwaukee (147), Madison (127), Green Bay (50), Marshfield (49), La Crosse (46), Stevens Point (44), Eau Claire (41), Weston (41), Sheboygan (36), Ashland (34), Rice Lake (34), Minocqua (30), Sturgeon Bay (29), Waukesha (29), Oshkosh (28), Wauwatosa (28), Appleton (27), Grafton (27), Mukwonago (27), Oconomowoc (27), Racine (27), Burlington (26), Germantown (26), Kenosha (26), Marinette (26), Summit (26), Two Rivers (25), Wausau (25), West Allis (25), Wisconsin Rapids (24), Antigo (23), New Richmond (23), Oconto Falls (23), Menomonee Falls (21), West Bend (21), Oak Creek (20), Rhinelander (20), Cudahy (17), Medford (17), Spooner (15), Superior (15), Neenah (13), New Berlin (13), Hayward (12), Janesville (12), Johnson Creek (11), Shawano (9), Berlin (8), Franklin (8), Waupaca (8), Brookfield (7), Chilton (7), Mequon (7), New London (7), Chippewa Falls (6), Ladysmith (5), Fond du Lac (3), Greenfield (2), Neillsville (2), Delafield (1), Hudson (1), West Salem (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Wisconsin

Basic details from each study's public record (the 12 most recently updated of 274). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Madison
    Registry record
    NCT07488676 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Wisconsin on ClinicalTrials.gov.

Prostate cancer: recently updated in Wisconsin

  1. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Madison
    Registry record
    NCT04038502 · updated
  2. High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Madison
    Registry record
    NCT05011383 · updated
  3. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Antigo · Eau Claire · Johnson Creek · and 10 more U.S. locations
    Registry record
    NCT04423211 · updated
  4. Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Milwaukee
    Registry record
    NCT06136624 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Wisconsin on ClinicalTrials.gov.

Melanoma: recently updated in Wisconsin

  1. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Marshfield · Menomonee Falls · Milwaukee · and 4 more U.S. locations
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Wisconsin on ClinicalTrials.gov.

Lymphoma: recently updated in Wisconsin

  1. Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eastern Cooperative Oncology Group
    Recruiting in
    Madison · Marshfield · Menomonee Falls · and 7 more U.S. locations
    Registry record
    NCT06724237 · updated
  2. A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Recruiting in
    Milwaukee
    Registry record
    NCT07221500 · updated
  3. A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    La Crosse · Madison
    Registry record
    NCT06717347 · updated
  4. A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Madison · Milwaukee
    Registry record
    NCT06890884 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Wisconsin on ClinicalTrials.gov.

Ask about studies in Wisconsin

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call